Does ECULIZUMAB Cause Metastatic malignant melanoma? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Metastatic malignant melanoma have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.0% of all adverse event reports for ECULIZUMAB.
6
Reports of Metastatic malignant melanoma with ECULIZUMAB
0.0%
of all ECULIZUMAB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Metastatic malignant melanoma From ECULIZUMAB?
Of the 6 reports, 3 (50.0%) resulted in death, 1 (16.7%) required hospitalization.
Is Metastatic malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Metastatic malignant melanoma?
DABRAFENIB (449)
TRAMETINIB DIMETHYL SULFOXIDE (267)
TRAMETINIB (173)
SILDENAFIL (116)
TALIMOGENE LAHERPAREPVEC (109)
NIVOLUMAB (87)
PREDNISONE (77)
PEMBROLIZUMAB (74)
TADALAFIL (71)
IPILIMUMAB (69)
Which ECULIZUMAB Alternatives Have Lower Metastatic malignant melanoma Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB